Florida Cancer Specialists President Lucio Gordan, MD To Lead Online Session on How COVID-19 Has Impacted Cancer Care
/
Date02 Jul 2020
Email Print Friendly Share President & Managing Physician Lucio Gordan, MD Fort Myers, Fla., July 01, 2020 (GLOBE NEWSWIRE) — Lucio Gordan, MD, President and... Read More →
RedHill Biopharma erhält Genehmigung für Phase-II/III-Studie zur Behandlung von COVID-19-Patienten mit Opaganib in Großbritannien
/
Date01 Jul 2020
Email Print Friendly Share In die multizentrische, randomisierte, doppelblinde und placebokontrollierte Parallelarmstudie der Phasen II/III zu Opaganib sollen 270 schwer erkrankte COVID-19-Patienten an bis zu... Read More →
The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy (“DGT”) clinical trial
/
Date30 Jun 2020
Email Print Friendly Share InFoods® Diagnostic-Guided Therapy is designed to identify patient-specific foods that, when removed from the diet, may alleviate an individual’s IBS symptoms... Read More →
Montreal Heart Institute announces COLCORONA trial in patients with COVID-19 passes futility test in interim analysis
/
Date28 Jun 2020
Email Print Friendly Share Dr. Jean-Claude Tardif Dr. Jean-Claude Tardif MONTREAL, June 26, 2020 (GLOBE NEWSWIRE) — Montreal Heart Institute today announced that the COLCORONA... Read More →
L'Institut de Cardiologie de Montréal (ICM) annonce que l'étude clinique COLCORONA des patients atteints de la COVID-19 a passé le test de la futilité
/
Date27 Jun 2020
Email Print Friendly Share Dr. Jean-Claude Tardif Dr. Jean-Claude Tardif MONTRÉAL, 26 juin 2020 (GLOBE NEWSWIRE) — L’Institut de Cardiologie de Montréal annonce aujourd’hui que... Read More →
Assure Holdings Enters into Agreement with First Health Group to Streamline Certain Commercial Insurance Claims at Pre-Determined Rates
/
Date25 Jun 2020
Email Print Friendly Share DENVER, June 24, 2020 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of... Read More →
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Europe
/
Date24 Jun 2020
Email Print Friendly Share LA JOLLA, Calif., June 23, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the... Read More →
Sumitovant Biopharma Announces Priority Review and FDA Acceptance of Myovant Sciences New Drug Application for Once-Daily, Oral Relugolix for Advanced Prostate Cancer
/
Date23 Jun 2020
Email Print Friendly Share LONDON and NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) — Sumitovant Biopharma is pleased to announce that the U.S. Food and... Read More →
Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for CONTEPO™ (fosfomycin) for injection
/
Date22 Jun 2020
Email Print Friendly Share DUBLIN, Ireland, June 19, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and... Read More →
Longer duration of sleep might help control COVID-19 symptoms, says AHMADZAI
/
Date21 Jun 2020
Email Print Friendly Share Photo: Meladul Haq Ahmadzai Meladul Haq Ahmadzai, CEO of Taleam Systems. OTTAWA, June 20, 2020 (GLOBE NEWSWIRE) — To address Corona... Read More →